[{"address1": "259 Liberty Avenue", "city": "Staten Island", "state": "NY", "zip": "10305", "country": "United States", "phone": "917 533 1469", "website": "https://www.acurxpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. DeLuccia", "age": 79, "title": "Co-Founder & Executive Chairman", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 818930, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.9, "open": 1.89, "dayLow": 1.89, "dayHigh": 2.0299, "regularMarketPreviousClose": 1.9, "regularMarketOpen": 1.89, "regularMarketDayLow": 1.89, "regularMarketDayHigh": 2.0299, "payoutRatio": 0.0, "beta": -1.218, "forwardPE": -0.5317139, "volume": 16386, "regularMarketVolume": 16386, "averageVolume": 59338, "averageVolume10days": 40010, "averageDailyVolume10Day": 40010, "bid": 1.86, "ask": 1.96, "bidSize": 1, "askSize": 1, "marketCap": 5017032, "fiftyTwoWeekLow": 1.89, "fiftyTwoWeekHigh": 21.0, "allTimeHigh": 176.4, "allTimeLow": 1.89, "fiftyDayAverage": 2.9418, "twoHundredDayAverage": 5.63619, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1798636, "profitMargins": 0.0, "floatShares": 1971148, "sharesOutstanding": 2546717, "sharesShort": 70856, "sharesShortPriorMonth": 80620, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0278, "heldPercentInsiders": 0.0505, "heldPercentInstitutions": 0.0759, "shortRatio": 1.28, "shortPercentOfFloat": 0.027999999, "impliedSharesOutstanding": 2546717, "bookValue": 2.02, "priceToBook": 0.97524756, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -9170053, "trailingEps": -8.18, "forwardEps": -3.705, "lastSplitFactor": "1:20", "lastSplitDate": 1754352000, "52WeekChange": -0.8717949, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 1.97, "targetHighPrice": 165.8, "targetLowPrice": 20.0, "targetMeanPrice": 61.7, "targetMedianPrice": 30.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 5906802, "totalCashPerShare": 2.833, "totalDebt": 0, "quickRatio": 2.409, "currentRatio": 2.474, "returnOnAssets": -0.95638, "returnOnEquity": -2.91065, "freeCashflow": -4876828, "operatingCashflow": -7853440, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ACXP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Acurx Pharmaceuticals, Inc.", "longName": "Acurx Pharmaceuticals, Inc.", "marketState": "CLOSED", "firstTradeDateMilliseconds": 1624627800000, "hasPrePostMarketData": true, "corporateActions": [], "postMarketTime": 1771025071, "regularMarketTime": 1771016402, "exchange": "NCM", "messageBoardId": "finmb_558025934", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.68421, "regularMarketPrice": 1.97, "postMarketChangePercent": -1.5076163, "postMarketPrice": 1.9403, "postMarketChange": -0.02970004, "regularMarketChange": 0.0700001, "regularMarketDayRange": "1.89 - 2.0299", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 59338, "fiftyTwoWeekLowChange": 0.08000004, "fiftyTwoWeekLowChangePercent": 0.042328067, "fiftyTwoWeekRange": "1.89 - 21.0", "fiftyTwoWeekHighChange": -19.03, "fiftyTwoWeekHighChangePercent": -0.9061905, "fiftyTwoWeekChangePercent": -87.17949, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "earningsCallTimestampStart": 1762952400, "earningsCallTimestampEnd": 1762952400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -8.18, "epsForward": -3.705, "epsCurrentYear": -5.71, "priceEpsCurrentYear": -0.34500876, "fiftyDayAverageChange": -0.9718001, "fiftyDayAverageChangePercent": -0.330342, "twoHundredDayAverageChange": -3.66619, "twoHundredDayAverageChangePercent": -0.6504731, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-25", "prevName": "Acurx Pharmaceuticals, LLC", "nameChangeDate": "2026-02-13", "cryptoTradeable": false, "displayName": "Acurx Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]